| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/07/2001 | WO2001040513A2 Method of diagnosing rheumatoid arthritis and method of treating rheumatoid arthritis |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040263A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040207A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040201A1 Oxazolidinone derivatives |
| 06/07/2001 | WO2001040192A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039775A1 Benzimidazole compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001039758A2 Method for the treatment and/or prophylaxis of diseases caused by il-12 using thalidomide and anti-inflammatory cytokine |
| 06/07/2001 | WO2001039723A2 Triazospiro compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2000074703B1 Therapeutic agent comprising a botulinum neurotoxin |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | US20010002999 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
| 06/07/2001 | DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2393265A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same |
| 06/07/2001 | CA2393217A1 Oxazolidinone derivatives |
| 06/07/2001 | CA2393190A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2391551A1 Methods for diagnosis and therapy of rheumatoid arthritis |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/06/2001 | EP1104762A1 Substituted imidazo 1,2a]azines as selective inhibotors of cox-2 |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104425A1 Novel thiazolopyrimidine compounds |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104421A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo 3,4-b]pyridine |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104411A1 Calcilytic compounds |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP1104236A1 Transdermally delivered aspirin |
| 06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298387A Process for the preparation of methyl (2S)-2-[(3R)-3-CN-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yL] propionate |
| 06/06/2001 | CN1298308A Inhibitors of complement activation |
| 06/06/2001 | CN1297750A Medicine for treating rheumatism, rheumatoid disease and hyperosteogeny |
| 06/06/2001 | CN1297749A External use medicine composition for promoting blood circulation and relieving pain |
| 06/06/2001 | CN1066734C Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/06/2001 | CN1066726C 吡咯衍生物 Azole derivatives |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242497 Use of 6,7-substituted 2-aminotetralines suitable for preparing a pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 06/05/2001 | US6242476 Leukotriene A4 hydrolase inhibitors |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242459 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 06/05/2001 | US6242453 Polycyclo heterocyclic derivatives as antiinflammatory agents |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6242419 Genes encoding proteins expressed in lymph node stromal cells from flaky skin (fsn-/-) mice and their use in therapy. |
| 06/05/2001 | US6242249 Nucleotide sequences of trigger factor chaperones from staphylococcus; diagnosis; probes; primers; vaccines; bactericides; bacteriostats; antibodies; drug screening |
| 06/05/2001 | US6242238 Nucleotide sequence which codes for heparinase; drug screening for antimetastasis/antinflammatory agents, angiogenesis inhibitors, wound healing agents; treatment for angioplasty-induced restenosis and atherosclerosis |
| 06/05/2001 | US6242229 Topically applying composition including clarified and stabilized culture medium from non-photosynthetic filamentous bacterium to skin, scalp, or mucous membranes; reduces or delays aging of skin |
| 06/05/2001 | US6242213 Nucleotide sequences coding preferential polypeptide for use in controlling immune response |
| 06/05/2001 | US6242000 Analgesic, antiinflammatory agent |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 05/31/2001 | WO2001038878A2 Pin1 as a marker for abnormal cell growth |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038552A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038316A2 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands |
| 05/31/2001 | WO2001038315A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001038303A2 Vitamin d analogues |
| 05/31/2001 | WO2001038295A1 Sphingosine derivatives |